D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 61 700 KRW -2.99% Market Closed
Market Cap: 553.9B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Dong-A ST Co Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dong-A ST Co Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
D
Dong-A ST Co Ltd
KRX:170900
Short-Term Investments
â‚©75.5B
CAGR 3-Years
7%
CAGR 5-Years
45%
CAGR 10-Years
16%
Yuhan Corp
KRX:000100
Short-Term Investments
â‚©19.1B
CAGR 3-Years
-56%
CAGR 5-Years
-34%
CAGR 10-Years
-21%
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Investments
â‚©1.4B
CAGR 3-Years
-84%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Investments
â‚©199B
CAGR 3-Years
154%
CAGR 5-Years
48%
CAGR 10-Years
9%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Investments
â‚©16B
CAGR 3-Years
-24%
CAGR 5-Years
-16%
CAGR 10-Years
5%
C
Celltrion Pharm Inc
KOSDAQ:068760
Short-Term Investments
â‚©15B
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dong-A ST Co Ltd
Glance View

Market Cap
530.5B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
95 195.66 KRW
Undervaluation 35%
Intrinsic Value
Price
D

See Also

What is Dong-A ST Co Ltd's Short-Term Investments?
Short-Term Investments
75.5B KRW

Based on the financial report for Jun 30, 2024, Dong-A ST Co Ltd's Short-Term Investments amounts to 75.5B KRW.

What is Dong-A ST Co Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
16%

Over the last year, the Short-Term Investments growth was 45%. The average annual Short-Term Investments growth rates for Dong-A ST Co Ltd have been 7% over the past three years , 45% over the past five years , and 16% over the past ten years .

Back to Top